GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (XTER:88Q) » Definitions » EV-to-FCF

4basebio (XTER:88Q) EV-to-FCF : -21.08 (As of May. 03, 2024)


View and export this data going back to 2021. Start your Free Trial

What is 4basebio EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, 4basebio's Enterprise Value is €159.41 Mil. 4basebio's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 was €-7.56 Mil. Therefore, 4basebio's EV-to-FCF for today is -21.08.

The historical rank and industry rank for 4basebio's EV-to-FCF or its related term are showing as below:

XTER:88Q' s EV-to-FCF Range Over the Past 10 Years
Min: -42.93   Med: -14.09   Max: -9.12
Current: -20.84

During the past 4 years, the highest EV-to-FCF of 4basebio was -9.12. The lowest was -42.93. And the median was -14.09.

XTER:88Q's EV-to-FCF is ranked worse than
100% of 391 companies
in the Biotechnology industry
Industry Median: 4.48 vs XTER:88Q: -20.84

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-03), 4basebio's stock price is €12.50. 4basebio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.591. Therefore, 4basebio's PE Ratio for today is At Loss.


4basebio EV-to-FCF Historical Data

The historical data trend for 4basebio's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio EV-to-FCF Chart

4basebio Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EV-to-FCF
- - -15.97 -13.01

4basebio Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EV-to-FCF Get a 7-Day Free Trial - -15.97 - -13.01 -

Competitive Comparison of 4basebio's EV-to-FCF

For the Biotechnology subindustry, 4basebio's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4basebio's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4basebio's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where 4basebio's EV-to-FCF falls into.



4basebio EV-to-FCF Calculation

4basebio's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=159.413/-7.564
=-21.08

4basebio's current Enterprise Value is €159.41 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 4basebio's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 was €-7.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


4basebio  (XTER:88Q) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

4basebio's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=12.50/-0.591
=At Loss

4basebio's share price for today is €12.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 4basebio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.591.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


4basebio EV-to-FCF Related Terms

Thank you for viewing the detailed overview of 4basebio's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


4basebio (XTER:88Q) Business Description

Traded in Other Exchanges
Address
25 Norman Way, Over, Cambridge, GBR, CB24 5QE
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (XTER:88Q) Headlines

No Headlines